Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingyan Liangsang
- Development stage
- Phase 2
- Lead developer
- Shaanxi Longhui Biological Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Qingyan Liangsang is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Shaanxi Longhui Biological Pharmaceutical Co., Ltd. for the treatment of acute pharyngitis and related throat conditions. Typically administered as granules (Qingyan Liangsang Keli), the product is composed of a blend of herbal ingredients traditionally used to clear heat, resolve toxicity, and soothe the pharynx. Its pharmacological effects include reducing inflammation and congestion in the pharyngeal mucosa, thereby alleviating symptoms such as sore throat, hoarseness, and dryness. As a TCM drug, it is widely used in the Chinese market for upper respiratory symptom management.
- Brand names
- Qingyan Liangsang
- Other names
- Qingyan Liangsang KeliQingyan Liangsang Granules
Beyond the preview
Go deeper on Qingyan Liangsang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qingyan Liangsang.